Tang Capital Management LLC Genfit S.A. Transaction History

Tang Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.97 - $3.94 $2.24 Million - $2.97 Million	-754,995 Reduced 61.16%	479,441 $1.85 Million
Q2 2023 Aug 14, 2023	BUY	$3.54 - $4.68 $77,600 - $102,590	21,921 Added 1.81%	1,234,436 $4.37 Million
Q1 2023 May 15, 2023	BUY	$3.93 - $4.69 $58,922 - $70,317	14,993 Added 1.25%	1,212,515 $4.97 Million
Q4 2022 Feb 14, 2023	SELL	$3.53 - $4.39 $225,637 - $280,608	-63,920 Reduced 5.07%	1,197,522 $5.26 Million
Q2 2022 Aug 15, 2022	BUY	$3.09 - $4.25 $278,350 - $382,844	90,081 Added 7.69%	1,261,442 $4.06 Million

Q1 2022 May 16, 2022	BUY	$3.14 - $5.04 $362,252 - $581,449	115,367 Added 10.92%	1,171,361 $4.69 Million
Q4 2021 Feb 14, 2022	BUY	$3.01 - $5.65 $3.18 Million - $5.97 Million	1,055,994 New	1,055,994 $5.28 Million

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tang Capital Management LLC with notifications on news.